Craniosynostosis syndromes: From genes to premature fusion of skull bones

Molecular Genetics and Metabolism

Volumn 68, Issue 2, 1999, Pages 139-151

  Hehr, Ute ^c   Muenke, Maximilian ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACROCEPHALOSYNDACTYLY; CONGENITAL MALFORMATION; CRANIOFACIAL SYNOSTOSIS; CROUZON SYNDROME; GENE DELETION; GENE DUPLICATION; GENE INSERTION; GENE MUTATION; PRIORITY JOURNAL; SHORT SURVEY; SYNDROME;

EID: 0032737329     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1006/mgme.1999.2915     Document Type: Article

References (114)

1. Shapiro R, Robinson F. The embryogenesis of the human skull. An anatomic and radiographic atlas. 1980;Harvard Univ. Press, Cambridge.
2. Wilkie A O. Craniosynostosis: genes and mechanisms. Hum Mol Genet. 6:1997;1647-1656.
3. Muenke M, Wilkie A OM. Craniosynostosis syndromes. Scriver. The Metabolic and Molecular Bases of Inherited Disease. 2000;McGraw-Hill Book Company, New York.
4. Gorlin R J, Cohen M M Jr, Levin L S. Syndromes of the head and neck. 1990;Oxford Univ. Press, New York.
5. Müller U, Warman M L, Mulliken J B, Weber J L. Assignment of a gene locus involved in craniosynostosis to chromosome 5qter. Hum Mol Genet. 2:1993;119-122.
6. Warman M L, Mulliken J B, Hayward P G, Müller U. Newly recognized autosomal dominant disorder with craniosynostosis. Am J Med Genet. 46:1993;444-449.
7. Jabs E W, Muller U, Li X, Ma L, Luo W, Haworth I S, Klisak I, Sparkes R, Warman M L, Mulliken J B. A mutation in the homeodomain of the human MSX2 gene in a family affected with autosomal dominant craniosynostosis. Cell. 75:1993;443-450.
8. Online Mendelian Inheritance in Man, OMIM (TM). Center for Medical Genetics, Johns Hopkins University (Baltimore, MD) and National Center for Biotechnology Information, National Library of Medicine (Bethesda, MD), 1999. World Wide Web URL, http://www.ncbi.nlm.nih.gov/omim/.
9. Cohen M M Jr. An etiologic and nosologic overview of craniosynostosis syndromes. Birth Defects Orig Artic Ser. 11:1975;137-189.
10. Cohen M M Jr. Craniosynostosis and syndromes with craniosynostosis: incidence, genetics, penetrance, variability, and new syndrome updating. Birth Defects Orig Artic Ser. 15:1979;13-63.
11. Wilkie A O, Slaney S F, Oldridge M, Poole M D, Ashworth G J, Hockley A D, Hayward R D, David D J, Pulleyn L J, Rutland P. Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome. Nat Genet. 9:1995;165-172.
12. Oldridge M, Lunt P W, Zackai E H, McDonald-McGinn D M, Muenke M, Moloney D M, Twigg S R, Heath J K, Howard T D, Hoganson G, Gagnon D M, Jabs E W, Wilkie A O. Genotype-phenotype correlation for nucleotide substitutions in the IgII-IgIII linker of FGFR2. Hum Mol Genet. 6:1997;137-143.
13. Oldridge M, Zackai E H, McDonald-McGinn D M, Iseki S, Morriss-Kay G M, Twigg S R, Johnson D, Wall S A, Jiang W, Theda C, Jabs E W, Wilkie A O. De novo alu-element insertions in FGFR2 identify a distinct pathological basis for Apert syndrome. Am J Hum Genet. 64:1999;446-461.
14. Pfeiffer R A. Dominant erbliche Akrocephalosyndaktylie. Z Kinderheilkunde. 90:1964;301-320.
15. Cohen M M Jr. Pfeiffer syndrome update, clinical subtypes, and guidelines for differential diagnosis. Am J Med Genet. 45:1993;300-307.
16. Robin N H, Feldman G J, Mitchell H F, Lorenz P, Wilroy R S, Zackai E H, Allanson J E, Reich E W, Pfeiffer R A, Clarke L A. Linkage of Pfeiffer syndrome to chromosome 8 centromere and evidence for genetic heterogeneity. Hum Mol Genet. 3:1994;2153-2158.
17. Schell U, Hehr A, Feldman G J, Robin N H, Zackai E H, de Die-Smulders C, Viskochil D H, Stewart J M, Wolff G, Ohashi H. Mutations in FGFR1 and FGFR2 cause familial and sporadic Pfeiffer syndrome. Hum Mol Genet. 4:1995;323-328.
18. Muenke M, Schell U, Hehr A, Robin N H, Losken H W, Schinzel A, Pulleyn L J, Rutland P, Reardon W, Malcolm S. A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome. Nat Genet. 8:1994;269-274.
19. Rutland P, Pulleyn L J, Reardon W, Baraitser M, Hayward R, Jones B, Malcolm S, Winter R M, Oldridge M, Slaney S F. Identical mutations in the FGFR2 gene cause both Pfeiffer and Crouzon syndrome phenotypes. Nat Genet. 9:1995;173-176.
20. Lajeunie E, Ma H W, Bonaventure J, Munnich A, Le Merrer M, Renier D. FGFR2 mutations in Pfeiffer syndrome. Nat Genet. 9:1995;108.
21. Meyers G A, Day D, Goldberg R, Daentl D L, Przylepa K A, Abrams L J, Graham J M Jr, Feingold M, Moeschler J B, Rawnsley E, Scott A F, Jabs E W. FGFR2 exon IIIa and IIIc mutations in Crouzon, Jackson-Weiss, and Pfeiffer syndromes: evidence for missense changes, insertions, and a deletion due to alternative RNA splicing. Am J Hum Genet. 58:1996;491-498.
22. Hollway G E, Suthers G K, Haan E A, Thompson E, David D J, Gecz J, Mulley J C. Mutation detection in FGFR2 craniosynostosis syndromes. Hum Genet. 99:1997;251-255.
23. Tartaglia M, Valeri S, Velardi F, Di Rocco C, Battaglia P A. Trp290Cys mutation in exon IIIa of the fibroblast growth factor receptor 2 (FGFR2) gene is associated with Pfeiffer syndrome. Hum Genet. 99:1997;602-606.
24. Gripp K W, Stolle C A, McDonald-McGinn D M, Markowitz R I, Bartlett S P, Katowitz J A, Muenke M, Zackai E H. Phenotype of the fibroblast growth factor receptor 2 ser351-to-cys mutation: Pfeiffer syndrome type III. Am J Med Genet. 78:1998;356-360.
25. Schaefer F, Anderson C, Can B, Say B. Novel mutation in the FGFR2 gene at the same codon as the Crouzon syndrome mutations in a severe Pfeiffer syndrome type 2 case. Am J Med Genet. 75:1998;252-255.
26. Anderson P J, Hall C M, Evans R D, Jones B M, Hayward R D. The feet in Pfeiffer's syndrome. J Craniofac Surg. 9:1998;83-87.
27. Cornejo-Roldan L R, Roessler E, Muenke M. Analysis of the mutational spectrum of the FGFR2 gene in Pfeiffer syndrome. Hum Genet. 104:1999;425-431.
28. Cohen M M Jr, McLean R E. Craniosynostosis: Diagnosis, Evaluation, and Management. 2000;Oxford University Press, New York.
29. Preston R A, Post J C, Keats B J, Aston C E, Ferrell R E, Priest J, Nouri N, Losken H W, Morris C A, Hurtt M R. A gene for Crouzon craniofacial dysostosis maps to the long arm of chromosome 10. Nat Genet. 7:1994;149-153.
30. Reardon W, Winter R M, Rutland P, Pulleyn L J, Jones B M, Malcolm S. Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome. Nat Genet. 8:1994;98-103.
31. Jabs E W, Li X, Scott A F, Meyers G, Chen W, Eccles M, Mao J I, Charnas L R, Jackson C E, Jaye M. Jackson-Weiss and Crouzon syndromes are allelic with mutations in fibroblast growth factor receptor 2. Nat Genet. 8:1994;275-279.
32. Oldridge M, Wilkie A O, Slaney S F, Poole M D, Pulleyn L J, Rutland P, Hockley A D, Wake M J, Goldin J H, Winter R M. Mutations in the third immunoglobulin domain of the fibroblast growth factor receptor-2 gene in Crouzon syndrome. Hum Mol Genet. 4:1995;1077-1082.
33. Gorry M C, Preston R A, White G J, Zhang Y, Singhal V K, Losken H W, Parker M G, Nwokoro N A, Post J C, Ehrlich G D. Crouzon syndrome: mutations in two spliceoforms of FGFR2 and a common point mutation shared with Jackson-Weiss syndrome. Hum Mol Genet. 4:1995;1387-1390.
34. Park W J, Meyers G A, Li X, Theda C, Day D, Orlow S J, Jones M C, Jabs E W. Novel FGFR2 mutations in Crouzon and Jackson-Weiss syndromes show allelic heterogeneity and phenotypic variability. Hum Mol Genet. 4:1995;1229-1233.
35. Pulleyn L J, Reardon W, Wilkes D, Rutland P, Jones B M, Hayward R, Hall C M, Brueton L, Chun N, Lammer E, Malcolm S, Winter R M. Spectrum of craniosynostosis phenotypes associated with novel mutations at the fibroblast growth factor receptor 2 locus. Eur J Hum Genet. 4:1996;283-291.
36. Steinberger D, Mulliken J B, Müller U. Crouzon syndrome: previously unrecognized deletion, duplication, and point mutation within FGFR2 gene. Hum Mutat. 8:1996;386-390.
37. Steinberger D, Collmann H, Schmalenberger B, Müller U. A novel mutation (a886g) in exon 5 of FGFR2 in members of a family with Crouzon phenotype and plagiocephaly. J Med Genet. 34:1997;420-422.
38. Hertz J M, Juncker I, MØlhave B, Sunde L, Christensen L, Østergaard J R, Kjeldssen M. Mutations in the FGFR2-gene in Crouzon syndrome. Eur J Hum Genet. 5:1997;155.
39. Steinberger D, Vriend G, Mulliken J B, Müller U. The mutations in FGFR2-associated craniosynostosis are clustered in five structural elements of immunoglobulin-like domain III of the receptor. Hum Genet. 102:1998;145-150.
40. Passos-Bueno M R, Sertie A L, Richieri-Costa A, Alonso L G, Zatz M, Alonso N, Brunoni D, Ribeiro S F. Description of a new mutation and characterization of FGFR1, FGFR2, and FGFR3 mutations among Brazilian patients with syndromic craniosynostoses. Am J Med Genet. 78:1998;237-241.
41. Jackson C E, Weiss L, Reynolds W A, Forman T F, Peterson J A. Craniosynostosis, midfacial hypoplasia and foot abnormalities: an autosomal dominant phenotype in a large Amish kindred. J Pediatr. 88:1976;963-968.
42. Tartaglia M, Di Rocco C, Lajeunie E, Valeri S, Velardi F, Battaglia P A. Jackson-Weiss syndrome: identification of two novel FGFR2 missense mutations shared with Crouzon and Pfeiffer craniosynostotic disorders. Hum Genet. 101:1997;47-50.
43. Bellus G A, Gaudenz K, Zackai E H, Clarke L A, Szabo J, Francomano C A, Muenke M. Identical mutations in three different fibroblast growth factor receptor genes in autosomal dominant craniosynostosis syndromes. Nat Genet. 14:1996;174-176.
44. Muenke M, Gripp K W, McDonald-McGinn D M, Gaudenz K, Whitaker L A, Bartlett S P, Markowitz R I, Robin N H, Nwokoro N, Mulvihill J J, Losken H W, Mulliken J B, Guttmacher A E, Wilroy R S, Clarke L A, Hollway G, Ades L C, Haan E A, Mulley J C, Cohen M M Jr, Bellus G A, Francomano C A, Moloney D M, Wall S A, Wilkie A O. A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome. Am J Hum Genet. 60:1997;555-564.
45. Gripp K W, McDonald-McGinn D M, Gaudenz K, Whitaker L A, Bartlett S P, Glat P M, Cassileth L B, Mayro R, Zackai E H, Muenke M. Identification of a genetic cause for isolated unilateral coronal synostosis: a unique mutation in the fibroblast growth factor receptor 3. J Pediatr. 132:1998;714-716.
46. Robin N H, Scott J A, Cohen A R, Goldstein J A. Nonpenetrance in FGFR3-associated coronal synostosis syndrome. Am J Med Genet. 80:1998;296-297.
47. Lajeunie E, El Ghouzzi V, Le Merrer M, Munnich A, Bonaventure J, Renier D. Sex related expressivity of the phenotype in coronal craniosynostosis caused by the recurrent P250R FGFR3 mutation. J Med Genet. 36:1999;9-13.
48. Beare J M, Dodge J A, Nevin N C. Cutis gyratum, acanthosis nigricans and other congenital anomalies: a new syndrome. Br J Dermatol. 81:1969;241-247.
49. Stevenson R E, Ferlauto G J, Taylor H A. Cutis gyratum and acanthosis nigricans associated with other anomalies: a distinctive syndrome. J Pediatr. 92:1978;950-952.
50. Hall B D, Cadle R G, Golabi M, Morris C A, Cohen M M Jr. Beare-Stevenson cutis gyrata syndrome. Am J Med Genet. 44:1992;82-89.
51. Andrews J M, Martins D M, Ramos R R, Ferreira L M. A severe case of Beare-Stevenson syndrome and associated congenital deformities. Br J Plast Surg. 46:1993;443-446.
52. Bratanic B, Praprotnik M, Novosel-Sever M. Congenital craniofacial dysostosis and cutis gyratum: the Beare-Stevenson syndrome. Eur J Pediatr. 153:1994;184-186.
53. Przylepa K A, Paznekas W, Zhang M, Golabi M, Bias W, Bamshad M J, Carey J C, Hall B D, Stevenson R, Orlow S, Cohen M M Jr, Jabs E W. Fibroblast growth factor receptor 2 mutations in Beare-Stevenson cutis gyrata syndrome. Nat Genet. 13:1996;492-494.
54. Krepelova A, Baxova A, Calda P, Plavka R, Kapras J. FGFR2 gene mutation (Tyr375Cys) in a new case of Beare-Stevenson syndrome. Am J Med Genet. 76:1998;362-364.
55. Gorlin R J. Fibroblast growth factors, their receptors and receptor disorders. J Craniomaxillofac Surg. 25:1997;69-79.
56. Meyers G A, Orlow S J, Munro I R, Przylepa K A, Jabs E W. Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans. Nat Genet. 11:1995;462-464.
57. Wilkes D, Rutland P, Pulleyn L J, Reardon W, Moss C, Ellis J P, Winter R M, Malcolm S. A recurrent mutation, ala391glu, in the transmembrane region of FGFR3 causes Crouzon syndrome and acanthosis nigricans. J Med Genet. 33:1996;744-748.
58. Reardon W, Winter R M. Saethre-Chotzen syndrome. J Med Genet. 31:1994;393-396.
59. Rose C S, King A A, Summers D, Palmer R, Yang S, Wilkie A O, Reardon W, Malcolm S, Winter R M. Localization of the genetic locus for Saethre-Chotzen syndrome to a 6 cM region of chromosome 7 using four cases with apparently balanced translocations at 7p21.2. Hum Mol Genet. 3:1994;1405-1408.
60. Wilkie A O, Yang S P, Summers D, Poole M D, Reardon W, Winter R M. Saethre-Chotzen syndrome associated with balanced translocations involving 7p21: three further families. J Med Genet. 32:1995;174-180.
61. Rose C S, Patel P, Reardon W, Malcolm S, Winter R M. The TWIST gene, although not disrupted in Saethre-Chotzen patients with apparently balanced translocations of 7p21, is mutated in familial and sporadic cases. Hum Mol Genet. 6:1997;1369-1373.
62. Howard T D, Paznekas W A, Green E D, Chiang L C, Ma N, Ortiz de Luna R I, Garcia Delgado C, Gonzalez-Ramos M, Kline A D, Jabs E W. Mutations in TWIST, a basic helix-loop-helix transcription factor, in Saethre-Chotzen syndrome. Nat Genet. 15:1997;36-41.
63. El Ghouzzi V, Le Merrer M, Perrin-Schmitt F, Lajeunie E, Benit P, Renier D, Bourgeois P, Bolcato-Bellemin A L, Munnich A, Bonaventure J. Mutations of the TWIST gene in the Saethre-Chotzen syndrome. Nat Genet. 15:1997;42-46.
64. Johnson D, Horsley S W, Moloney D M, Oldridge M, Twigg S R, Walsh S, Barrow M, Njolstad P R, Kunz J, Ashworth G J, Wall S A, Kearney L, Wilkie A O. A comprehensive screen for TWIST mutations in patients with craniosynostosis identifies a new microdeletion syndrome of chromosome band 7p21.1. Am J Hum Genet. 63:1998;1282-1293.
65. Isshiki T, Takeichi M, Nose A. The role of the msh homeobox gene during Drosophila neurogenesis: implication for the dorsoventral specification of the neuroectoderm. Development. 124:1997;3099-3109.
66. Zhang H, Hu G, Wang H, Sciavolino P, Iler N, Shen M M, Abate-Shen C. Heterodimerization of Msx and Dlx homeoproteins results in functional antagonism. Mol Cell Biol. 17:1997;2920-2932.
67. Winograd J, Reilly M P, Roe R, Lutz J, Laughner E, Xu X, Hu L, Asakura T, vander Kolk C, Strandberg J D, Semenza G L. Perinatal lethality and multiple craniofacial malformations in MSX2 transgenic mice. Hum Mol Genet. 6:1997;369-379.
68. Weiss K M, Ruddle F H, Bollekens J. Dlx and other homeobox genes in the morphological development of the dentition. Connect Tissue Res. 32:1995;35-40.
69. Foerst-Potts L, Sadler T W. Disruption of Msx-1 and Msx-2 reveals roles for these genes in craniofacial, eye, and axial development. Dev Dyn. 209:1997;70-84.
70. Kim H J, Rice D P, Kettunen P J, Thesleff I. FGF-, BMP- and Shh-mediated signalling pathways in the regulation of cranial suture morphogenesis and calvarial bone development. Development. 125:1998;1241-1251.
71. Ma L, Golden S, Wu L, Maxson R. The molecular basis of Boston-type craniosynostosis: the Pro148 → His mutation in the N-terminal arm of the MSX2 homeodomain stabilizes DNA binding without altering nucleotide sequence preferences. Hum Mol Genet. 5:1996;1915-1920.
72. Newberry E P, Latifi T, Battaile J T, Towler D A. Structure-function analysis of Msx2-mediated transcriptional suppression. Biochemistry. 36:1997;10451-11062.
73. Liu Y H, Kundu R, Wu L, Luo W, Ignelzi M A Jr, Snead M L, Maxson R E Jr. Premature suture closure and ectopic cranial bone in mice expressing Msx2 transgenes in the developing skull. Proc Natl Acad Sci USA. 92:1995;6137-6141.
74. Twigg S R, Burns H D, Oldridge M, Heath J K, Wilkie A O. Conserved use of a non-canonical 5′ splice site (/GA) in alternative splicing by fibroblast growth factor receptors 1, 2 and 3. Hum Mol Genet. 7:1998;685-691.
75. Goldfarb M. Functions of fibroblast growth factors in vertebrate development. Cytokine Growth Factor Rev. 7:1996;311-325.
76. Bellot F, Crumley G, Kaplow J M, Schlessinger J, Jaye M, Dionne C A. Ligand-induced transphosphorylation between different FGF receptors. EMBO J. 10:1991;2849-2854.
77. Marshall C J. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell. 80:1995;179-185.
78. Klint P, Claesson-Welsh L. Signal transduction by fibroblast growth factor receptors. Front Biosci. 4:1999;165-177.
79. Peters K G, Werner S, Chen G, Williams L T. Two FGF receptor genes are differentially expressed in epithelial and mesenchymal tissues during limb formation and organogenesis in the mouse. Development. 114:1992;233-243.
80. Delezoide A L, Benoist-Lasselin C, Legeai-Mallet L, Le Merrer M, Munnich A, Vekemans M, Bonaventure J. Spatio-temporal expression of FGFR 1, 2 and 3 genes during human embryo-fetal ossification. Mech Dev. 77:1998;19-30.
81. Deng C, Bedford M, Li C, Xu X, Yang X, Dunmore J, Leder P. Fibroblast growth factor receptor-1 (FGFR-1) is essential for normal neural tube and limb development. Dev Biol. 185:1997;42-54.
82. Ciruna B G, Schwartz L, Harpal K, Yamaguchi T P, Rossant J. Chimeric analysis of fibroblast growth factor receptor-1 (Fgfr1) function: a role for FGFR1 in morphogenetic movement through the primitive streak. Development. 124:1997;2829-2841.
83. Schell-Hehr U, Hehr A, Muenke M. Fibroblast growth factor receptors and their role in human dysmorphogenesis. Edwards Y, Swallow D. Human Molecular Genetics: Protein Dysfunction in Human Genetic Disease. 1997;Bios Scientific, Oxford.
84. Schaefer F, Anderson C, Can B, Say B. Novel mutation in the FGFR2 gene at the same codon as the Crouzon syndrome mutations in a severe Pfeiffer syndrome type 2 case. Am J Med Genet. 75:1998;252-255.
85. Moloney D M, Wall S A, Ashworth G J, Oldridge M, Glass I A, Francomano C A, Muenke M, Wilkie A O. Prevalence of Pro250Arg mutation of fibroblast growth factor receptor 3 in coronal craniosynostosis. Lancet. 12:1997;1059-1062.
86. Moloney D M, Slaney S F, Oldridge M, Wall S A, Sahlin P, Stenman G, Wilkie A O. Exclusive paternal origin of new mutations in Apert syndrome. Nat Genet. 13:1996;48-53.
87. Li X, Park W J, Pyeritz R E, Jabs E W. Effect on splicing of a silent FGFR2 mutation in Crouzon syndrome. Nat Genet. 9:1995;232-233.
88. Yamaguchi T P, Harpal K, Henkemeyer M, Rossant J. fgfr-1 is required for embryonic growth and mesodermal patterning during mouse gastrulation. Genes Dev. 8:1994;3032-3044.
89. Deng C X, Wynshaw-Boris A, Shen M M, Daugherty C, Ornitz D M, Leder P. Murine FGFR-1 is required for early postimplantation growth and axial organization. Genes Dev. 8:1994;3045-3057.
90. Arman E, Haffner-Krausz R, Chen Y, Heath J K, Lonai P. Targeted disruption of fibroblast growth factor (FGF) receptor 2 suggests a role for FGF signaling in pregastrulation mammalian development. Proc Natl Acad Sci USA. 95:1998;5082-5087.
91. Deng C, Wynshaw-Boris A, Zhou F, Kuo A, Leder P. Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell. 84:1996;911-921.
92. Colvin J S, Bohne B A, Harding G W, McEwen D G, Ornitz D M. Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3. Nat Genet. 12:1996;390-397.
93. Galvin B D, Hart K C, Meyer A N, Webster M K, Donoghue D J. Constitutive receptor activation by Crouzon syndrome mutations in fibroblast growth factor receptor (FGFR)2 and FGFR2/Neu chimeras. Proc Natl Acad Sci USA. 93:1996;7894-7899.
94. Neilson K M, Friesel R. Ligand-independent activation of fibroblast growth factor receptors by point mutations in the extracellular, transmembrane, and kinase domains. J Biol Chem. 271:1996;25049-25057.
95. Mangasarian K, Li Y, Mansukhani A, Basilico C. Mutation associated with Crouzon syndrome causes ligand-independent dimerization and activation of FGF receptor-2. J Cell Physiol. 172:1997;117-125.
96. Robertson S C, Meyer A N, Hart K C, Galvin B D, Webster M K, Donoghue D J. Activating mutations in the extracellular domain of the fibroblast growth factor receptor 2 function by disruption of the disulfide bond in the third immunoglobulin-like domain. Proc Natl Acad Sci USA. 95:1998;4567-4572.
97. Anderson J, Burns H D, Enriquez-Harris P, Wilkie A OM, Heath J K. Apert syndrome mutations in fibroblast growth factor receptor 2 exhibit increased affinity for FGF ligand. Hum Mol Genet. 7:1998;1475-1483.
98. Chen Z F, Behringer R R. twist is required in head mesenchyme for cranial neural tube morphogenesis. Genes Dev. 15:1995;686-699.
99. Murre C, Bain G, van Dijk M A, Engel I, Furnari B A, Massari M E, Matthews J R, Quong M W, Rivera R R, Stuiver M H. Structure and function of helix-loop-helix proteins. Biochim Biophys Acta. 1218:1994;129-135.
100. Rose C S, Malcolm S. A TWIST in development. Trends Genet. 13:1997;384-387.
101. Wang S M, Coljee V W, Pignolo R J, Rotenberg M O, Cristofalo V J, Sierra F. Cloning of the human twist gene: its expression is retained in adult mesodermally-derived tissues. Gene. 187:1997;83-92.
102. Baylies M K, Bate M. twist: a myogenic switch in Drosophila. Science. 272:1996;1481-1484.
103. Gitelman I. Twist protein in mouse embryogenesis. Dev Biol. 189:1997;205-214.
104. Thisse B, Stoetzel C, Gorostiza-Thisse C, Perrin-Schmitt F. Sequence of the twist gene and nuclear localization of its protein in endomesodermal cells of early Drosophila embryos. EMBO J. 7:1988;2175-2183.
105. Krebs I, Weis I, Hudler M, Rommens J M, Roth H, Scherer S W, Tsui L C, Fuchtbauer E M, Grzeschik K H, Tsuji K, Kunz J. Translocation breakpoint maps 5 kb 3′ from TWIST in a patient affected with Saethre-Chotzen syndrome. Hum Mol Genet. 6:1997;1079-1086.
106. Patel P, Reardon W, Malcolm S, Winter R M. Translocation breakpoints mapped approximately 70-250 kb from the TWIST gene in three patients with Saethre-Chotzen syndrome. J Med Genet. 35:1998;S78.
107. Bourgeois P, Bolcato-Bellemin AL, Danse J M, Bloch-Zupan A, Yoshiba K, Stoetzel C, Perrin-Schmitt F. The variable expressivity and incomplete penetrance of the twist-null heterozygous mouse phenotype resemble those of human Saethre-Chotzen syndrome. Hum Mol Genet. 7:1998;945-957.
108. Shishido E, Ono N, Kojima T, Saigo K. Requirements of DFR1/Heartless, a mesoderm-specific Drosophila FGF-receptor, for the formation of heart, visceral and somatic muscles, and ensheathing of longitudinal axon tracts in CNS. Development. 124:1997;2119-2128.
109. Shishido E, Higashijima S, Emori Y, Saigo K. Two FGF-receptor homologues of Drosophila: one is expressed in mesodermal primordium in early embryos. Development. 117:1993;751-761.
110. Lord P C, Lin M H, Hales K H, Storti R V. Normal expression and the effects of ectopic expression of the Drosophila muscle segment homeobox (msh) gene suggest a role in differentiation and patterning of embryonic muscles. Dev Biol. 171:1995;627-640.
111. D'Alessio M, Frasch M. msh may play a conserved role in dorsoventral patterning of the neuroectoderm and mesoderm. Mech Dev. 58:1996;217-231.
112. Paznekas W A, Cunningham M L, Howard T D, Korf B R, Lipson M H, Grix A W, Feingold M, Goldberg R, Borochowitz Z, Aleck K, Mulliken J, Yin M, Jabs E W. Genetic heterogeneity of Saethre-Chotzen syndrome, due to TWIST and FGFR mutations. Am J Hum Genet. 62:1998;1370-1380.
113. Robin, N, H, Craniosynostosis Syndromes (FGFR-related). GeneClinics, Copyright © 1997-1998 University of Washington, 1998, http://www.geneclinics.org .
114. Johnson D E, Williams L T. Structural and functional diversity in the FGF receptor multigene family. Van de Woude G F, Klein G. Advances in Cancer Research. 1993;Academic Press, San Diego.